Lepirudin
Lepirudin is a pharmaceutical drug that acts as an anticoagulant, specifically functioning as a direct thrombin inhibitor. It is used in the prevention and treatment of thrombotic events.
Brand and Generic Names[edit]
- Brand Name: Refludan
- Generic Name: Lepirudin rDNA for injection
Chemical Composition[edit]
Lepirudin is a recombinant version of hirudin, which is naturally found in the saliva of the medicinal leech (Hirudo medicinalis)[1]. The recombinant version is derived from yeast cells. Its structure is almost identical to the natural hirudin except for two modifications:
- Substitution of leucine for isoleucine at the N-terminal end
- Absence of a sulfate group on the tyrosine at position 63
Medical Use[edit]
Lepirudin is primarily employed as an anticoagulant in cases where patients exhibit heparin-induced thrombocytopenia. In such cases, traditional anticoagulants such as heparin (unfractionated or low-molecular-weight) may be contraindicated.
Market Withdrawal[edit]
In 2012, Bayer, the pharmaceutical company producing Lepirudin, announced its decision to cease its production. As of May 31, 2012, Lepirudin (Refludan) was no longer available in the marketCite error: Invalid <ref> tag; refs with no name must have content.
References[edit]
- ↑ , Antithrombotic Drug Therapy in Cardiovascular Disease. online version, Springer, ISBN 978-1-60327-234-6, Pages: 440–,
| Antithrombotics (thrombolytics, anticoagulants and antiplatelet drugs) (B01) | ||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian